Companies / BOC Sciences / Lucatumumab
BOC Sciences

Lucatumumab | BOC Sciences

Lucatumumab is a human anti-CD40 monoclonal antibody. Lucatumumab blocks the interaction of CD40 and its ligand CD40L, inhibiting CD40L-mediated proliferation of normal B cells, CLL cells and non-Hodgkin lymphoma cells. Lucatumumab also mediates antibody-dependent cell-mediated cytotoxicity (ADCC).

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.
  • See More